Inducibility of UDP-glucuronosyltransferase 1As by β-naphthoflavone in HepG2 cells

Food and Chemical Toxicology

Volumn 44, Issue 8, 2006, Pages 1251-1260

  Hanioka, Nobumitsu ^a   Obika, Nobuhiko ^a   Nishimura, Masuhiro ^b   Jinno, Hideto ^c   Tanaka Kagawa, Toshiko ^c   Saito, Keita ^a   Kiryu, Kimio ^b   Naito, Shinsaku ^b   Narimatsu, Shizuo ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

naphthoflavone (BNF); HepG2 cells; Inducibility; inducibility; UDP glucuronosyltransferase (UGT); UGT1A

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; ENVIRONMENTAL CHEMICAL; ENZYME; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A6; GLUCURONOSYLTRANSFERASE 1A9; HYMECROMONE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GLUCURONIDATION; HEPATOMA CELL; HILL REACTION; HUMAN; HUMAN CELL; KINETICS; LIVER; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BETA-NAPHTHOFLAVONE; CELL LINE, TUMOR; ENZYME INDUCTION; GLUCURONOSYLTRANSFERASE; HUMANS; KINETICS; LIVER; MICROSOMES, LIVER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33745200956     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2006.01.019     Document Type: Article

References (47)

1. Abid A., Bouchon I., Siest G., and Sabolovic N. Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1*6. Biochem. Pharmacol. 50 (1995) 557-561
2. Abid A., Sabolovic N., and Magdalou J. Expression and inducibility of UDP-glucuronosyltransferases 1-naphthol in human cultured hepatocytes and hepatocarcinoma cell lines. Life Sci. 60 (1997) 1943-1951
3. Ando Y., Saka H., Ando M., Sawa T., Muro K., Ueoka H., Yokoyama A., Saitoh S., Shimokata K., and Hasegawa Y. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res. 60 (2000) 6921-6926
4. Ando Y., Saka H., Asai G., Sugiura S., Shimokata K., and Kamataki T. UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann. Oncol. 9 (1998) 845-857
5. Beutler E., Gelbart T., and Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?. Proc. Natl. Acad. Sci. USA 95 (1998) 8170-8174
6. Bock K.W., and Lilienblum W. Roles of uridine diphosphate glucuronosyltransferase in chemical carcinogenesis. In: Kauffman F.C. (Ed). Handbook of Experimental Pharmacology (1994), Springer, Heidelberg 392-428
7. Bock K.W., Gschaidmeier H., Heel H., Lehmköster T., Münzel P.A., and Bock-Hennig B.S. Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metab. Rev. 31 (1999) 411-422
8. Bock K.W., Wiltfang J., Blume R., Ullrich D., and Bircher J. Paracetamol as a test drug to determine glucuronide formation in man: effects of inducers and of smoking. Eur. J. Clin. Pharmacol. 31 (1987) 677-683
9. Bock-Hennig B.S., Köhle C., Nill K., and Bock K.W. Influence of t-butylhydroquinone and β-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers. Biochem. Pharmacol. 63 (2002) 123-128
10. Bosma P.J., Chowdhury J.R., Bakker C., Gantla S., de Boer A., Oostra B.A., Lindhout D., Tytgat G.N., Jansen P.L., Oude Elferink R.P., and Chowdhury N.R. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 333 (1995) 1171-1175
11. Burchell B., Brierley C.H., Monaghan G., and Clarke D.J. The structure and function of the UDP-glucuronosyltransferase gene family. Adv. Pharmacol. 42 (1998) 335-338
12. Burchell B., Brierley C.H., and Rance D. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci. 57 (1995) 1819-1831
13. Dutton G.J. Glucuronidation of Drugs and Other Compounds (1980), CRC Press, Boca Raton
14. Ekins S., Maenpaa J., and Wrighton S.A. In vitro metabolism: subcelluar fractions. In: Woolf T.F. (Ed). Handbook of Drug Metabolism (1999), Marcel Dekker, New York 363-399
15. Galijatovic A., Otake Y., Walle U.K., and Walle T. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells: potential role in carcinogen bioinactivation. Pharm. Res. 18 (2001) 374-379
16. Grove A.D., Kessler F.K., Metz R.P., and Ritter J.K. Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol. J. Biol. Chem. 272 (1997) 1621-1627
17. Guengerich F.P. Role of cytochrome P450 enzymes in drug-drug interactions. Adv. Pharmacol. 43 (1997) 7-35
18. Hanioka N., Ozawa S., Jinno H., Ando M., Saito Y., and Sawada J. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. Xenobiotica 31 (2001) 687-699
19. Hanioka N., Jinno H., Tanaka-Kagawa T., Nishimura T., and Ando M. Determination of UDP-glucuronosyltransferase UGT1A6 activity in human and rat liver microsomes by HPLC with UV detection. J. Pharm. Biomed. Anal. 25 (2001) 65-75
20. Hecht S.S., Carmella S.G., and Murphy S.E. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 907-913
21. Hum D.W., Bélanger A., Lévesque E., Barbier O., Beaulieu M., Albert C., Vallée M., Guillemette C., Tchernof A., Turgeon D., and Dubois S. Characterization of UDP-glucuronosyltransferases active on steroid hormones. J. Steroid Biochem. Mol. Biol. 69 (1999) 413-423
22. Iyer L., Das S., Janisch L., Wen M., Ramirez J., Karrison T., Fleming G.F., Vokes E.E., Schilsky R.L., and Ratain M.J. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J. 2 (2002) 43-47
23. Iyer L., Hall D., Das S., Mortell M.A., Ramirez J., Kim S., Di Rienzo A., and Ratain M.J. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin. Pharmacol. Ther. 65 (1999) 576-582
24. Iyer L., King C.D., Whitington P.F., Green M.D., Roy S.K., Tephly T.R., Coffman B.L., and Ratain M.J. Genetic predisposition to the metabolism of irinotecan (CPT-11): role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J. Clin. Invest. 101 (1998) 847-854
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
26. Mackenzie P.I., Owens I.S., Burchell B., Bock K.W., Bairoch A., Bélanger A., Fournel-Gigleux S., Green M., Hum D.W., Iyanagi T., Lancet D., Louisot P., Magdalou J., Chowdhury J.R., Ritter J.K., Schachter H., Tephly T.R., Tipton K.F., and Nebert D.W. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7 (1997) 255-269
27. Miners J.O., Attwood J., and Birkett D.J. Determinants of acetaminophen metabolism: effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clin. Pharmacol. Ther. 35 (1984) 480-486
28. Miners J.O., and Mackenzie P.I. Drug glucuronidation in humans. Pharmacol. Ther. 51 (1991) 347-869
29. Monaghan G., Clarke D.J., Povey S., See C.G., Boxer M., and Burchell B. Isolation of a human YAC contig encompassing a cluster of UGT2 genes and its regional localization to chromosome 4q13. Genomics 23 (1994) 496-499
30. Münzel P.A., Lehmköster T., Brück M., Ritter J.K., and Bock K.W. Aryl hydrocarbon receptor-inducible or constitutive expression of human UDP glucuronosyltransferase UGT1A6. Arch. Biochem. Biophys. 350 (1998) 72-78
31. Münzel P.A., Schmohl S., Heel H., Kälberer K., Bock-Hennig B.S., and Bock K.W. Induction of human UDP glucuronosyltransferases (UGT1A6, UGT1A9, and UGT2B7) by t-butylhydroquinone and 2,3,7,8-tetrachlorodibenzo-p-dioxin in Caco-2 cells. Drug Metab. Dispos. 27 (1999) 569-573
32. Nishimura M., and Naito S. Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. Biol. Pharm. Bull. 28 (2005) 886-892
33. Nishimura M., Yoshitsugu H., Naito S., and Hiraoka I. Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 122 (2002) 339-361
34. Pantuck E.J., Pantuck C.B., Anderson K.E., Wattenberg L.W., Conney A.H., and Kappas A. Effect of brussels sprouts and cabbage on drug conjugation. Clin. Pharmacol. Ther. 35 (1984) 161-169
35. Radominska-Pandya A., Czernik P.J., Little J.M., Battaglia E., and Mackenzie P.I. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab. Rev. 31 (1999) 817-899
36. Ritter J.K. Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem. Biol. Interact. 129 (2000) 171-193
37. Ritter J.K., Chen F., Sheen Y.Y., Tran H.M., Kimura S., Yeatman M.T., and Owens I.S. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J. Biol. Chem. 267 (1992) 3257-3261
38. Ritter J.K., Kessler F.K., Thompson M.T., Grove A.D., Auyeung D.J., and Fisher R.A. Expression and inducibility of the human bilirubin UDP-glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: evidence for both genetic and environmental influences. Hepatology 30 (1999) 476-484
39. Soars M.G., Petullo D.M., Eckstein J.A., Kasper S.C., and Wrighton S.A. An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes. Drug Metab. Dispos. 32 (2004) 140-148
40. Sugatani J., Kojima H., Ueda A., Kakizaki S., Yoshinari K., Gong Q.H., Owens I.S., Negishi M., and Sueyoshi T. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 33 (2001) 1232-1238
41. Sugatani J., Yamakawa K., Tonda E., Nishitani S., Yoshinari K., Degawa M., Abe I., Noguchi H., and Miwa M. The induction of human UDP-glucuronosyltransferase 1A1 mediated through a distal enhancer module by flavonoids and xenobiotics. Biochem. Pharmacol. 67 (2004) 989-1000
42. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 581-616
43. Uchaipichat V., Mackenzie P.I., Guo X.H., Gardner-Stephen D., Galetin A., Houston J.B., and Miners J.O. Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Drug Metab. Dispos. 32 (2004) 413-423
44. Walle T., Otake Y., Galijatovic A., Ritter J.K., and Walle U.K. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line Hep G2. Drug Metab. Dispos. 28 (2000) 1077-1082
45. Walle U.K., and Walle T. Induction of human UDP-glucuronosyltransferase UGT1A1 by flavonoids-structural requirements. Drug Metab. Dispos. 30 (2002) 564-569
46. de Wildt S.N., Kearns G.L., Leeder J.S., and van den Anker J.N. Glucuronidation in humans: pharmacogenetic and developmental aspects. Clin. Pharmacokinet. 36 (1999) 439-452
47. Xie W., Yeuh M.F., Radominska-Pandya A., Saini S.P., Negishi Y., Bottroff B.S., Cabrera G.Y., Tukey R.H., and Evans R.M. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. USA 100 (2003) 4150-4155